The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Why Humana Stock Dropped Today

04:16pm, Thursday, 25'th Jan 2024
Humana announced a surprise quarterly loss on higher medical cost trends to end 2023. Management also issued disappointing forward earnings guidance.
Steve Weiss, Short Hills Capital Partners founder and managing partner, joins 'Halftime Report' to share his latest healthcare trades.
Humana (HUM) expects 2024 revenues to increase to around $113 billion.
The medical cost increases reflect an increasing number of older adults returning to hospitals to undergo procedures they had delayed during the pandemic.
While the top- and bottom-line numbers for Humana (HUM) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare
Humana (NYSE:HUM) shares tumbled more than 10% in early trade as the Kentucky-based health insurance firm warned its 2024 profits are expected to be impacted by higher costs associated with its Medica
Humana (HUM) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to earnings of $1.62 per share a year ago.

Humana Dives On Huge 2024 Earnings Warning

07:30am, Thursday, 25'th Jan 2024
The health insurer says 2024 earnings will be barely half of estimates due to higher Medicare Advantage costs.
Sector components forecast to show the biggest earnings year-over-year earnings improvement include Humana Inc. NYSE: HUM, Elevance Health Inc. NYSE: ELV, Incyte Corp. NASDAQ: INCY, Insulet Corp.
Humana Inc.'s stock HUM, -1.26% fell 17% early Thursday, after the managed care company's quarterly loss widened amid soaring medial costs. Humana posted a loss of $491 million, or $4.42 a share, for
Humana Inc forecast 2024 profit sharply below Wall Street estimates on Thursday as it expects higher costs within its Medicare Advantage plans for older adults to persist into 2024, sending the compan
The company reports earnings before the market open Thursday.
Evaluate the expected performance of Humana (HUM) for the quarter ended December 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics f
Humana's (HUM) Q4 results are likely to gain from growing premiums and an expanding customer base within its individual Medicare Advantage and Medicaid units, partly offset by higher marketing spend.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE